Filtros de búsqueda

Lista de obras de

A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1

artículo científico publicado en 2018

Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations

artículo científico publicado en 2020

Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse

artículo científico publicado en 2018

COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial

artículo científico publicado en 2020

Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy

artículo científico publicado en 2019

Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres

scientific article published on 28 December 2018

Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials

artículo científico publicado en 2018

Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial)

scientific article published on 20 August 2018

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

artículo científico publicado en 2020

Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services.

artículo científico publicado en 2017

Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy

scientific article published on 21 May 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda